Mannkind reported $2.63M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adma Biologics ADMA:US USD 20K 0
Eli Lilly And LLY:US USD 594.1M 0
Halozyme Therapeutics HALO:US USD 135K 3K
Immunogen IMGN:US USD 2.21M 2K
Insmed INSM:US USD 1.22M 18K
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Mannkind MNKD:US USD 2.63M 59K
Minerva Neurosciences NERV:US USD 1000 0
Novavax NVAX:US USD 792K 4K
Novo Nordisk A Fs NVO:US DKK 456M 0
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Xencor XNCR:US USD 598K 0